{"id":10041,"date":"2020-02-18T00:00:00","date_gmt":"2020-02-17T23:00:00","guid":{"rendered":"https:\/\/idibell.cat\/es\/blog\/2020\/02\/18\/la-comision-europea-concede-al-idibell-dos-becas-individuales-marie-sklodowska-curie\/"},"modified":"2020-05-19T09:47:47","modified_gmt":"2020-05-19T07:47:47","slug":"la-comision-europea-concede-al-idibell-dos-becas-individuales-marie-sklodowska-curie","status":"publish","type":"post","link":"https:\/\/idibell.cat\/es\/2020\/02\/la-comision-europea-concede-al-idibell-dos-becas-individuales-marie-sklodowska-curie\/","title":{"rendered":"La Comisi\u00f3n Europea concede al IDIBELL dos becas individuales Marie Sklodowska-Curie"},"content":{"rendered":"<p>El pasado 3 de febrero se hicieron p\u00fablicos los resultados de la convocatoria 2019 del programa europeo \u2018Acciones Individuales Marie Sklodowska-Curie\u2019 (MSCA IF). El objetivo de esta iniciativa es promover la movilidad e innovaci\u00f3n del capital intelectual de Europa. Para ello, cuenta con un presupuesto (esta edici\u00f3n, de 296.49 M\u20ac) destinado a subvencionar la formaci\u00f3n y contrataci\u00f3n de investigadores con experiencia,\u00a0 que llevar\u00e1n a cabo proyectos individuales de entre uno y tres a\u00f1os de duraci\u00f3n.<\/p>\n<p>El Instituto de Investigaci\u00f3n Biom\u00e9dica de Bellvitge (IDIBELL) se beneficiar\u00e1 de esta oportunidad y acoger\u00e1 dos de estos proyectos:<\/p>\n<ul>\n<li>Por un lado, el proyecto RegARcis estudiar\u00e1, de la mano de la Dra. Rana El Bizri, el rol del complejo SWI\/SNF en la regulaci\u00f3n del cistroma del Receptor Androg\u00e9nico. La investigaci\u00f3n se llevar\u00e1 a cabo en el Grupo de Mecanismos de resistencia y progresi\u00f3n en el c\u00e1ncer de pr\u00f3stata, liderado por el Dr. \u00c1lvaro Aytes.<\/li>\n<li>Por otro lado, la Dra. Noem\u00ed Gonz\u00e1lez emprender\u00e1 el proyecto Organ-VIP, para desarrollar organoides gen\u00e9ticamente modificados que puedan ayudar en la interpretaci\u00f3n de variantes gen\u00e9ticas del c\u00e1ncer colorrectal, junto a la Dra. Laura Valle y su Grupo de C\u00e1ncer Hereditario.<\/li>\n<\/ul>\n<p>En esta convocatoria MSCA IF 2019, Espa\u00f1a se ha posicionado como el pa\u00eds de la Uni\u00f3n Europea con m\u00e1s proyectos financiados, recibiendo un total de 30.5 millones de euros. Estos fondos permitir\u00e1n la contrataci\u00f3n de casi 200 cient\u00edficos y cient\u00edficas en centros espa\u00f1oles. Un talento investigador que se suma a los m\u00e1s de 7830 proyectos que actualmente se est\u00e1n desarrollando gracias a estas ayudas, 861 de ellos en instituciones espa\u00f1olas.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>El pasado 3 de febrero se hicieron p\u00fablicos los resultados de la convocatoria 2019 del programa europeo \u2018Acciones Individuales Marie Sklodowska-Curie\u2019 (MSCA IF). El objetivo de esta iniciativa es promover la movilidad e innovaci\u00f3n del capital intelectual de Europa. Para ello, cuenta con un presupuesto (esta edici\u00f3n, de 296.49 M\u20ac) destinado a subvencionar la formaci\u00f3n [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":10042,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[184,250,254,281],"tags":[],"class_list":["post-10041","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-area-cancer","category-cancer-hereditario","category-mecanismos-de-resistencia-y-progresion-en-el-cancer-de-prostata","category-programa-de-mecanismos-moleculares-y-terapia-experimental-en-oncologia-oncobell"],"publishpress_future_action":{"enabled":false,"date":"2025-04-19 21:28:41","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/10041","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=10041"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/10041\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media\/10042"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=10041"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/categories?post=10041"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/tags?post=10041"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}